Lattice Biologics Ltd
OTC:LBLTF
Lattice Biologics Ltd
Research & Development
Lattice Biologics Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lattice Biologics Ltd
XTSX:LBL
|
Research & Development
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Research & Development
-$8.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Research & Development
-$5.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Research & Development
-$7.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-6%
|
|
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
Research & Development
-$98m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-17%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Research & Development
-$3.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-15%
|
|
Lattice Biologics Ltd
Glance View
Lattice Biologics, Ltd. is a biotech company. The company is headquartered in Scottsdale, Arizona. The firm is a precision medicine company in the field of cellular therapies and tissue engineering, with a focus on bone, skin and cartilage regeneration. The company produces and distributes multiple allograft tissue products used by surgeons as bone, skin and cartilage tissue void fillers. Its products include Acellular Demineralized Bone Scaffold, Demineralized Bone Matrix putty (DBM Putty), Acellular dermal matrix (ADM) dermal scaffold and Other Products. Its products are used in a range of applications, including enhancing fusion in spine surgery; enhancing breast reconstruction post mastectomy; sports medicine indications, including anterior cruciate ligament repair and promotion of bone growth in foot; promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries.
See Also
What is Lattice Biologics Ltd's Research & Development?
Research & Development
0
USD
Based on the financial report for Sep 30, 2020, Lattice Biologics Ltd's Research & Development amounts to 0 USD.
